-
Stokes MJ. Black cohosh use in menopause. Altern Med Alert 2003;6(9):97-101.
-
Coker Ross C. Anticancer potential of turmeric. Altern Med Alert 2003;6(9):104-108.
-
It has long been assumed that acetaminophen, the common analgesic agent, is relatively safe for people with known coronary artery disease, in contrast to NSAIDs and COX-2 inhibitors. But assumptions can be dangerous, and this small study suggests that acetaminophen use may have similar risks associated with it, specifically increases in blood pressure.
-
A murine model was employed to assess the effects of chronic stress on metastatic breast cancer spread. The researchers used a variety of tools to investigate the neuroendocrine, molecular, and cellular effects of chronic stress in this setting. Their findings suggest that chronic stress induces a significant increase in the extent of cancer spread through the activity of the sympathetic nervous system. The findings open numerous research questions yet to be answered, as well as great therapeutic possibilities.
-
Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.
-
A shift has occurred in recent years from viewing menopause as "a natural life event" experienced by women to "a condition that requires medical management."
-
Laboratory science has delineated convincing connections between vitamin D and immune system function, some of which have been borne out in clinical trials on the prevention and treatment of respiratory infections.
-
FDA Advisory Committee recommends approval of dabigatran, safety of proton pump inhibitors, effectiveness of glucosamine and chondroitin, FDA Actions.
-
A unique study pairing the use of a standard SSRI and SAMe against major depression in subjects who had not responded adequately to SSRI monotherapy suggests safety and significant efficacy over a 6-week trial period.
-
Results of this methodologically sound trial strongly suggest that moderate-dose B vitamin therapy has a protective effect against the rapidly progressive brain atrophy commonly seen in elderly people with mild cognitive impairment (MCI). The intervention was safe and effective over a 2-year time frame, and shows promise for slowing the inexorable progression of MCI to frank dementia.
